CVS Health Corp (NYSE:CVS) shares traded 1.81% higher at $62.45 on Wall Street last session.
CVS stock price is now -5.21% away from the 50-day moving average and 5.08% away from the 200-day moving average. The market capitalization of the company currently stands at $79.00B.
With the price target enhanced from $55 to $75, Leerink Partners Upgraded its rating from Market Perform to Outperform for CVS Health Corp (NYSE: CVS)., while ‘Edward Jones’ rates the stock as ‘Buy’
In other news, ROBBINS LARRY, Director sold 2,276,068 shares of the company’s stock on May 02 ’25. The stock was sold for $154,444,758 at an average price of $67.86. Upon completion of the transaction, the Director now directly owns 9,670,731 shares in the company, valued at $603.94 million. An SEC document containing details of the transaction can be found on the SEC’s website. On May 05 ’25, Director ROBBINS LARRY sold 1,323,932 shares of the business’s stock. A total of $89,249,945 was realized by selling the stock at an average price of $67.41. This leaves the insider owning 8,346,799 shares of the company worth $521.26 million. A total of 0.15% of the company’s stock is owned by insiders.
During the past 12 months, CVS Health Corp has had a low of $43.56 and a high of $72.51. As of last week, the company has a debt-to-equity ratio of 1.06, a current ratio of 0.82, and a quick ratio of 0.63.
The net profit margin was 1.39% and return on equity was 7.00% for CVS. The company reported revenue of $94.59 billion for the quarter, compared to $88.44 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 6.96 percent.
